{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:06:12Z","timestamp":1759104372871},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tubercle and Lung Disease"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1054\/tuld.1998.0199","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T15:33:28Z","timestamp":1032449608000},"page":"145-151","source":"Crossref","is-referenced-by-count":11,"title":["Propelling novel vaccines directed against tuberculosis through the regulatory process"],"prefix":"10.1054","volume":"79","author":[{"given":"M.J.","family":"Brennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/tuld.1998.0199_RF1","unstructured":"Ryan, F, The forgotten plague. How the battle against tuberculosis was won \u2013 and lost, Little, Brown, Boston, MA, 1993"},{"key":"10.1054\/tuld.1998.0199_RF2","series-title":"Tuberculosis, pathogenesis, protection, and control","first-page":"13","article-title":"History of tuberculosis","author":"Daniel","year":"1994"},{"key":"10.1054\/tuld.1998.0199_RF3","first-page":"213","article-title":"Global tuberculosis incidence and mortality during 1990\u20132000","volume":"72","author":"Dolin","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1054\/tuld.1998.0199_RF4","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1054\/tuld.1998.0199_RF5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","article-title":"Field trials of tuberculosis vaccines: how could we have done better","volume":"15","author":"Comstock","year":"1994","journal-title":"Contr Clin Trials"},{"key":"10.1054\/tuld.1998.0199_RF6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.257.5073.1055","article-title":"Tuberculosis: commentary on a re-emergent killer","volume":"257","author":"Bloom","year":"1992","journal-title":"Science"},{"key":"10.1054\/tuld.1998.0199_RF7","first-page":"585","volume":"40","year":"1991","journal-title":"Morb Mort Weekly Rep"},{"key":"10.1054\/tuld.1998.0199_RF8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1001\/jama.1996.03540230066037","article-title":"Sharpen available tools for tuberculosis control, but new tools needed for elimination","volume":"276","author":"Miller","year":"1996","journal-title":"JAMA"},{"key":"10.1054\/tuld.1998.0199_RF9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1146\/annurev.mi.49.100195.003233","article-title":"Prospects for new interventions in the treatment and prevention of mycobacterial disease","volume":"49","author":"Young","year":"1995","journal-title":"Ann Rev Microbiol"},{"key":"10.1054\/tuld.1998.0199_RF10","first-page":"149","article-title":"Tuberculosis: a global overview of the situation today","volume":"70","author":"Sudre","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1054\/tuld.1998.0199_RF11","series-title":"Tuberculosis","first-page":"3","article-title":"The origins of M. tuberculosis and the notion of its contagiousness","author":"Haas","year":"1996"},{"key":"10.1054\/tuld.1998.0199_RF12","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.95.23.13881","article-title":"Modeling the impact of global tuberculosis control strategies: implications of expanding the WHO strategy","volume":"95","author":"Murray","year":"1998","journal-title":"Proc Natl Acad Sci, USA"},{"key":"10.1054\/tuld.1998.0199_RF13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJM199106063242307","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"324","author":"Barnes","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1054\/tuld.1998.0199_RF14","first-page":"38","volume":"45","year":"1996","journal-title":"M M W R"},{"key":"10.1054\/tuld.1998.0199_RF15","series-title":"Vaccines: new approaches to immunological problems","first-page":"23","article-title":"Recent advances in the development of pertussis vaccines","author":"Brennan","year":"1991"},{"key":"10.1054\/tuld.1998.0199_RF16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of thirteen acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"10.1054\/tuld.1998.0199_RF17","first-page":"1","volume":"45","year":"1996","journal-title":"M M W R"},{"key":"10.1054\/tuld.1998.0199_RF18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000474915","article-title":"Optimal BCG treatment of superficial bladder cancer as defined by American trials","volume":"21","author":"Lamm","year":"1992","journal-title":"Eur Urol"},{"key":"10.1054\/tuld.1998.0199_RF19","unstructured":"USFDA Guidance for Industry \u2013 The sourcing and processing of gelatin to reduce the potential risk posed by bovine spongiform encephalopathy (BSE) in FDA-regulated products, http:/www.fda.gov./cber/guidelines.htm, 1997"},{"key":"10.1054\/tuld.1998.0199_RF20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/biol.1997.0071","article-title":"The Jennerian heritage: new generation vaccines for all the world's children and adults","volume":"25","author":"Nossa","year":"1997","journal-title":"Biologicals"},{"key":"10.1054\/tuld.1998.0199_RF21","first-page":"95","article-title":"Progress in the development of new vaccines against tuberculosis","volume":"1","author":"Orme","year":"1997","journal-title":"Int J Tuber Lung Dis"},{"key":"10.1054\/tuld.1998.0199_RF22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm0396-334","article-title":"Auxotrophic vaccines for tuberculosis","volume":"2","author":"Guleria","year":"1996","journal-title":"Nature Med"},{"key":"10.1054\/tuld.1998.0199_RF23","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1054\/tuld.1998.0199_RF24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nature Med"},{"key":"10.1054\/tuld.1998.0199_RF25","unstructured":"USFDA guidance document concerning the use of pilot manufacturing facilities for the development and manufacturing of biological products, http:/www.fda.gov/cber/guidelines.htm, 1995"},{"key":"10.1054\/tuld.1998.0199_RF26","series-title":"Tuberculosis","first-page":"893","article-title":"Bacillus of Calmette and Guerin (BCG) vaccine","author":"Huebner","year":"1996"},{"key":"10.1054\/tuld.1998.0199_RF27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0378-1135(93)90033-4","article-title":"Potency testing of bacterial vaccines for human use","volume":"37","author":"Habig","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1054\/tuld.1998.0199_RF28","series-title":"Bacterial vaccines","first-page":"69","article-title":"Pertussis","author":"Manclark","year":"1984"},{"key":"10.1054\/tuld.1998.0199_RF29","first-page":"133","article-title":"A study in active immunization against pertussis","volume":"29","author":"Kendrick","year":"1939","journal-title":"Am J Hyg"},{"key":"10.1054\/tuld.1998.0199_RF30","first-page":"51059","volume":"50","year":"1985","journal-title":"Federal Register"},{"key":"10.1054\/tuld.1998.0199_RF31","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"key":"10.1054\/tuld.1998.0199_RF32","doi-asserted-by":"crossref","first-page":"S484","DOI":"10.1093\/clinids\/11.Supplement_2.S484","article-title":"Evaluation of the protective potency of new tuberculosis vaccines","volume":"11","author":"Wiegeshaus","year":"1989","journal-title":"Rev Infec Dis"},{"key":"10.1054\/tuld.1998.0199_RF33","first-page":"543","article-title":"A co-operative evaluation of test systems used to assay tuberculosis vaccines","volume":"45","author":"Wiegeshaus","year":"1971","journal-title":"Bull World Health Organ"},{"key":"10.1054\/tuld.1998.0199_RF34","series-title":"Mycobacteria","first-page":"292","article-title":"Animal models for tuberculosis research","author":"Collins","year":"1997"},{"key":"10.1054\/tuld.1998.0199_RF35","series-title":"Tuberculosis","first-page":"259","article-title":"Pathogenicity of Mycobacterium tuberculosis in experimental animals","author":"Collins","year":"1996"},{"key":"10.1054\/tuld.1998.0199_RF36","series-title":"Tuberculosis, pathogenesis, protection, and control","first-page":"149","article-title":"The rabbit model of tuberculosis","author":"Dannenberg","year":"1994"},{"key":"10.1054\/tuld.1998.0199_RF37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm0496-430","article-title":"The Philippine cynamolgus monkey (Macaca fasicularis) provides a new non-human primate model of tuberculosis that resembles human disease","volume":"2","author":"Walsh","year":"1996","journal-title":"Nat Med"},{"key":"10.1054\/tuld.1998.0199_RF38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0171-2985(11)80472-9","article-title":"Advances in mycobacterial genetics: new promises for old diseases","volume":"184","author":"Jacobs","year":"1992","journal-title":"Immunobiol"},{"key":"10.1054\/tuld.1998.0199_RF39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/IAI.63.3.1004-1012.1995","article-title":"In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis","volume":"63","author":"McAdam","year":"1995","journal-title":"Infect Immun"},{"key":"10.1054\/tuld.1998.0199_RF40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/CritRevImmunol.v17.i2.20","article-title":"DNA vaccines \u2013 A modern gimmick or a boon to vaccinology","volume":"17","author":"Manickan","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1054\/tuld.1998.0199_RF41","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1172\/JCI119094","article-title":"Induction of neonatal tolerance by plasmid DNA vaccination of mice","volume":"98","author":"Mor","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1054\/tuld.1998.0199_RF42","series-title":"New generation vaccines","first-page":"1185","article-title":"The role of the Food and Drug Administration in vaccine testing and licensure","author":"Anthony","year":"1997"},{"key":"10.1054\/tuld.1998.0199_RF43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J053v05n01_01","article-title":"Nutritional abnormalities in infectious diseases effects on tuberculosis and AIDS","volume":"5","author":"Taylor","year":"1997","journal-title":"J Nutrit Immunol"},{"key":"10.1054\/tuld.1998.0199_RF44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J053v05n01_02","article-title":"Nutritional determinants of resistance to tuberculosis","volume":"5","author":"McMurray","year":"1997","journal-title":"J Nutrit Immunol"}],"container-title":["Tubercle and Lung Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096284799890199X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096284799890199X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:28:27Z","timestamp":1682141307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096284799890199X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S096284799890199X"],"URL":"https:\/\/doi.org\/10.1054\/tuld.1998.0199","relation":{},"ISSN":["0962-8479"],"issn-type":[{"value":"0962-8479","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}